Selank 10MG
$37.00
Selank is a synthetic heptapeptide developed as an analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide, extended with a Pro-Gly-Pro sequence that increases its resistance to enzymatic degradation.
Published research characterizes it as a modulator of GABAergic and monoaminergic signaling and of BDNF expression, with reported effects on the expression of genes associated with those pathways in animal models. Compared with unmodified tuftsin, the Pro-Gly-Pro extension gives it a substantially longer half-life in plasma.
Researchers study Selank in:
- GABA-A receptor expression studies
- Monoamine and serotonin turnover assays
- BDNF expression research
- Tuftsin analog structure-activity studies
- Peptide stability research
For research use only. Not for human or veterinary use.
MECHANISM
Selank operates through several overlapping pathways in the brain and immune system:
| GABA System Modulation | Serotonin & Dopamine Regulation |
|---|---|
| Selank’s primary anti-anxiety effect comes from its interaction with GABA-A receptors the same system targeted by benzodiazepines. The key difference: Selank modulates this system without overstimulating it, producing calm without sedation or dependence. | Selank influences serotonin and dopamine pathways the neurotransmitters responsible for mood, motivation, and emotional stability. Researchers observe mood-balancing effects without the emotional blunting associated with traditional psychiatric medications. |
| BDNF Upregulation | Immune System Support |
|---|---|
| Like Semax, Selank boosts BDNF the protein that supports neuron growth and brain plasticity. This is what gives it cognitive benefits alongside its anxiolytic effects: less anxiety and better mental performance at the same time. | As a tuftsin analog, Selank retains immune-modulating properties. Research shows it can support immune function and has demonstrated antiviral activity in preclinical models a unique feature not found in most neuropeptides. |
The result in research models: reduced anxiety, improved mood stability, better focus and memory all without the trade-offs of sedation, cognitive impairment, or addiction risk that come with conventional anxiolytics.
PHYSICAL PROPERTIES
Key specifications for handling and storage in laboratory settings:
| Peptide Structure | Synthetic heptapeptide — Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Molecular Weight | 751.9 g/mol |
| Form | White lyophilized powder |
| Solubility | Water-soluble |
| Purity | 98%+ (HPLC verified) |
| Administration | Intranasal (most common in research) or subcutaneous injection |
| Storage | Refrigerated 36-46 F (2-8 C). Protect from light. |
| Stability | 24 months lyophilized. Use within 30 days once reconstituted. |
POTENTIAL SIDE EFFECTS IN RESEARCH
Potential Side Effects in Research
Selank is considered one of the safest neuropeptides in current research. Side effects are uncommon, generally mild, and well-tolerated across study models. Researchers should monitor and document all observations.
| Nasal Irritation | Mild Headache |
|---|---|
| The most commonly reported observation with intranasal administration. Temporary dryness or mild irritation in the nasal passage. Typically resolves quickly. | Occasionally reported in some research subjects. Generally mild and short-lived. No serious cases documented at standard research concentrations. |
| Fatigue | Sore Throat |
|---|---|
| Mild fatigue noted in a small number of subjects, particularly early in a protocol. Usually transient and not dose-limiting. | Mild throat irritation occasionally reported following intranasal administration. Short-lived and resolves without intervention. |
| Nausea | Injection Site Irritation |
|---|---|
| Rarely observed. Mild and transient when reported. More common at higher concentrations in research protocols. | Minor redness or swelling at the injection site when administered subcutaneously. Typical of peptide administration and resolves quickly. |
No serious adverse effects have been documented at standard research concentrations. Selank does not produce the sedation, dependency, or withdrawal effects associated with conventional anxiolytic compounds.
DISCLAIMER
This product is exclusively for laboratory research. Not approved for human or veterinary use.
All products sold by Ikon Peptides are intended exclusively for in-vitro laboratory research. Not approved for human consumption or veterinary use. These statements have not been evaluated by the FDA.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Related products
